Biogen Stops Development Of Drug For Lou Gehrig’s Disease
Biogen Idec has announced that dexpramipexole, an experimental drug for the treatment of amyotrophic lateral sclerosis (ALS), commonly known as
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓